P2-378: MALE PATIENTS WITH EARLY STAGE ALZHEIMER DISEASE HAVE STRESS IN HOSPITAL

2014 ◽  
Vol 10 ◽  
pp. P616-P617
Author(s):  
Yumi Umeda-Kameyama ◽  
Katsuya Iijima ◽  
Kiyoshi Yamaguchi ◽  
Kiwami Kidana ◽  
Masayuki Honda ◽  
...  
Keyword(s):  
Alzheimer Disease ◽  
Early Stage ◽  
Male Patients

A novel biomarker to detect early-stage Alzheimer disease

2011 ◽  
Vol 7 (8) ◽  
pp. 420-420 ◽  
Author(s):  
Katy Malpass
Keyword(s):  
Alzheimer Disease ◽  
Early Stage

scholarly journals Mitochondrial DNA mutations increase in early stage Alzheimer disease and are inconsistent with oxidative damage

2016 ◽  
Vol 80 (2) ◽  
pp. 301-306 ◽  
Author(s):  
Jake G. Hoekstra ◽  
Michael J. Hipp ◽  
Thomas J. Montine ◽  
Scott R. Kennedy
Keyword(s):  
Mitochondrial Dna ◽  
Alzheimer Disease ◽  
Oxidative Damage ◽  
Early Stage ◽  
Mitochondrial Dna Mutations ◽  
Dna Mutations

scholarly journals Association of epileptiform abnormalities and seizures in Alzheimer disease

Neurology ◽  
2020 ◽  
Vol 95 (16) ◽  
pp. e2259-e2270 ◽  
Author(s):  
Alice D. Lam ◽  
Rani A. Sarkis ◽  
Kyle R. Pellerin ◽  
Jin Jing ◽  
Barbara A. Dworetzky ◽  
...  
Keyword(s):  
Alzheimer Disease ◽  
Late Onset ◽  
Early Stage ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Cognitively Normal ◽  
Scalp Eeg ◽  
Epileptiform Discharges ◽  
Potential Biomarker ◽  
The Relationship

ObjectiveTo examine the relationship between scalp EEG biomarkers of hyperexcitability in Alzheimer disease (AD) and to determine how these electric biomarkers relate to the clinical expression of seizures in AD.MethodsIn this cross-sectional study, we performed 24-hour ambulatory scalp EEGs on 43 cognitively normal elderly healthy controls (HC), 41 participants with early-stage AD with no history or risk factors for epilepsy (AD-NoEp), and 15 participants with early-stage AD with late-onset epilepsy related to AD (AD-Ep). Two epileptologists blinded to diagnosis visually reviewed all EEGs and annotated all potential epileptiform abnormalities. A panel of 9 epileptologists blinded to diagnosis was then surveyed to generate a consensus interpretation of epileptiform abnormalities in each EEG.ResultsEpileptiform abnormalities were seen in 53% of AD-Ep, 22% of AD-NoEp, and 4.7% of HC. Specific features of epileptiform discharges, including high frequency, robust morphology, right temporal location, and occurrence during wakefulness and REM, were associated with clinical seizures in AD. Multiple EEG biomarkers concordantly demonstrated a pattern of left temporal lobe hyperexcitability in early stages of AD, whereas clinical seizures in AD were often associated with bitemporal hyperexcitability. Frequent small sharp spikes were specifically associated with epileptiform EEGs and thus identified as a potential biomarker of hyperexcitability in AD.ConclusionEpileptiform abnormalities are common in AD but not all equivalent. Specific features of epileptiform discharges are associated with clinical seizures in AD. Given the difficulty recognizing clinical seizures in AD, these EEG features could provide guidance on which patients with AD are at high risk for clinical seizures.

scholarly journals The Physical Performance Test Predicts Aerobic Capacity Sufficient for Independence in Early-Stage Alzheimer Disease

2012 ◽  
Vol 35 (2) ◽  
pp. 72-78 ◽  
Author(s):  
Eric D. Vidoni ◽  
Sandra A. Billinger ◽  
Charesa Lee ◽  
Jenna Hamilton ◽  
Jeffrey M. Burns
Keyword(s):  
Alzheimer Disease ◽  
Physical Performance ◽  
Aerobic Capacity ◽  
Performance Test ◽  
Early Stage ◽  
Physical Performance Test

scholarly journals Aerobic Exercise Sustains Performance of Instrumental Activities of Daily Living in Early-Stage Alzheimer Disease

2019 ◽  
Vol 42 (3) ◽  
pp. E129-E134 ◽  
Author(s):  
Eric D. Vidoni ◽  
Jaime Perales ◽  
Mohammed Alshehri ◽  
Abdul-Mannaan Giles ◽  
Catherine F. Siengsukon ◽  
...  
Keyword(s):  
Alzheimer Disease ◽  
Activities Of Daily Living ◽  
Aerobic Exercise ◽  
Daily Living ◽  
Early Stage ◽  
Instrumental Activities

Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease

2008 ◽  
Vol 202 (1-3) ◽  
pp. 37-51 ◽  
Author(s):  
Evelin L. Schaeffer ◽  
Orestes V. Forlenza ◽  
Wagner F. Gattaz
Keyword(s):  
Alzheimer Disease ◽  
Phospholipase A2 ◽  
Therapeutic Approach ◽  
Cognitive Enhancement ◽  
Early Stage

scholarly journals Resource Utilisation and Costs of Depressive Patients in Germany: Results from the Primary Care Monitoring for Depressive Patients Trial

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Christian Krauth ◽  
Jona T. Stahmeyer ◽  
Juliana J. Petersen ◽  
Antje Freytag ◽  
Ferdinand M. Gerlach ◽  
...  
Keyword(s):  
Primary Care ◽  
Economic Burden ◽  
Early Stage ◽  
Resource Utilisation ◽  
Study Results ◽  
Significant Burden ◽  
Male Patients ◽  
Cost Categories ◽  
High Level ◽  
Depressive Patients

Background.Depression is the most common type of mental disorder in Germany. It is associated with a high level of suffering for individuals and imposes a significant burden on society. The aim of this study was to estimate the depression related costs in Germany taking a societal perspective.Materials and Methods.Data were collected from the primary care monitoring for depressive patients trial (PRoMPT) of patients with major depressive disorder who were treated in a primary care setting. Resource utilisation and days of sick leave were observed and analysed over a 1-year period.Results.Average depression related costs of €3813 were calculated. Significant differences in total costs due to sex were demonstrated. Male patients had considerable higher total costs than female patients, whereas single cost categories did not differ significantly. Further, differences in costs according to severity of disease and age were observed. The economic burden to society was estimated at €15.6 billion per year.Conclusion.The study results show that depression poses a significant economic burden to society. There is a high potential for prevention, treatment, and patient management innovations to identify and treat patients at an early stage.

Tau deposition and microglial activation in the living brain of early-stage Alzheimer disease

2017 ◽  
Vol 381 ◽  
pp. 127-128
Author(s):  
T. Terada ◽  
T. Bunai ◽  
T. Matsudaira ◽  
Y. Araki ◽  
A. Sugiura ◽  
...  
Keyword(s):  
Alzheimer Disease ◽  
Microglial Activation ◽  
Early Stage

Mild Cognitive Impairment Is Early-Stage Alzheimer Disease

2006 ◽  
Vol 63 (1) ◽  
pp. 15 ◽  
Author(s):  
John C. Morris
Keyword(s):  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Alzheimer Disease ◽  
Early Stage
Sign in / Sign up

Export Citation Format

Share Document